Global Cell And Gene Therapy Contract Research Organization Industry Trends and Market Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy contract research organization market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Cell And Gene Therapy Contract Research Organization Market from 2026 to 2030?
The cell and gene therapy contract research organization market size has experienced significant expansion recently. This market is projected to expand from $6.92 billion in 2025 to $7.76 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. Historically, this market’s expansion has been driven by factors such as an escalating volume of early-stage cell and gene therapy initiatives, constraints in internal development capacities, the advancement of rare disease research pipelines, the increasing intricacy of regulatory frameworks for advanced therapies, and a greater dependence on external research knowledge.
The cell and gene therapy contract research organization market size is anticipated to experience substantial expansion over the next few years. It is expected to reach $12.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period is primarily driven by escalating clinical trial activity in gene therapies, the broadening scope of personalized medicine development, increased investments in oncology and genetic disorder research, a growing requirement for accelerated development timelines, and strengthening collaborations between biotechnology companies and CROs. Significant trends anticipated in this period include the rising outsourcing of cell and gene therapy research, an increasing demand for integrated preclinical and clinical services, an enhanced focus on regulatory and compliance expertise, the expansion of vector development and manufacturing support, and more sophisticated utilization of data-driven trial management.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33057&type=smp
What Drivers Are Affecting Demand In The Cell And Gene Therapy Contract Research Organization Market?
The increasing emphasis on personalized medicine and targeted therapeutics is projected to fuel the expansion of the cell and gene therapy contract research organization (CRO) market in the future. These approaches entail creating treatments customized to a patient’s unique genetic, molecular, or cellular profile, aiming to enhance effectiveness and minimize unwanted side effects. The heightened attention on personalized medicine stems from regulators and healthcare systems giving precedence to precision therapies for managing intricate diseases and attaining superior clinical outcomes. Cell and gene therapy contract research organizations (CROs) play a crucial role in personalized medicine by offering expert preclinical, clinical, and regulatory support essential for the development, testing, and validation of sophisticated gene- and cell-based therapeutic products. As an illustration, in April 2025, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the Food and Drug Administration (FDA) sanctioned 18 personalized medicines in 2024, which represented approximately 38% of all newly approved therapeutic molecular entities. Consequently, the growing emphasis on personalized medicine and targeted therapeutics is a key factor propelling the expansion of the cell and gene therapy contract research organization (CRO) market.
Which Segment Groups Are Influencing The Cell And Gene Therapy Contract Research Organization Market?
The cell and gene therapy contract research organization market covered in this report is segmented –
1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types
2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services
3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications
4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies
5) By Application: Hospital; Research Institute; Other Applications
Subsegments:
1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services
2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services
3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services
Which Competitive Trends Are Impacting The Structure Of The Cell And Gene Therapy Contract Research Organization Market?
Major companies operating in the cell and gene therapy contract research organization (CRO) market are concentrating on developing innovative solutions, such as expanded laboratory and analytical services, to enhance therapy development efficiency, regulatory compliance, and research precision by providing state-of-the-art facilities, specialized equipment, and integrated cell and gene therapy testing capabilities. Expanded laboratory and analytical services refer to contract research organization (CRO) offerings that increase capacity, enable complex assay execution, and support sponsors with end-to-end development of advanced cell and gene therapies. For instance, in August 2025, Labcorp Holdings Inc., a US-based healthcare company, expanded its cell and gene therapy laboratory in madison, wisconsin, thereby strengthening its capabilities for cell characterization, vector analytics, and regulatory-compliant testing. The expanded facility provides specialized infrastructure for complex cell and gene therapy workflows, supports high-throughput sample processing, and integrates advanced analytical platforms, making it a comprehensive solution for accelerating cell and gene therapy research and development.
Who Are The Top-Performing Companies In The Cell And Gene Therapy Contract Research Organization Market In Recent Years?
Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Cell And Gene Therapy Contract Research Organization Market?
North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell And Gene Therapy Contract Research Organization Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33057&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Research Organization Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
